Your Molecule. Our Mission.
Cambrex is a leading
global contract development and manufacturing organization (CDMO) that provides
drug substance development and manufacturing across the entire drug lifecycle,
as well as comprehensive analytical and IND enabling services.
With over 40 years of experience and a team of
2,000 experts servicing global clients from North America and Europe, Cambrex
offers a range of specialized drug substance technologies and capabilities,
including continuous flow, controlled substances, solid-state science, material
characterization, and highly potent APIs.
Cambrex
-
US
-
2015On CPHI since
-
1000 - 4999Employees
Other Content from Cambrex (1)
-
News CPHI Pharma Awards 2023 – API Development and Innovation Winners: Snapdragon Chemistry, a Cambrex Company
After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October. In this series of interviews, we speak to the teams behind the award-winning projects, concepts, and technologies.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance